Theranostics · 2012 · 53 citations · 19 references
PharmacyBioengineeringOncologyDrug DeliveryNanomaterialsNanoparticle Drug DeliveryCancer NanomedicineNanocarriers For TherapeuticsNanomaterials For Drug DeliveryNanomedicineNanoparticle CharacterizationNanoparticle Delivery SystemsIron Oxide NanoparticlesNanoparticle Contrast AgentsNanoparticle Imaging AgentsNanoparticle Imaging ProbesNanoparticle PermeationNanoparticle-based Contrast AgentsTargetingTumor Vasculature Targeting
Iron oxide nanoparticles are a useful diagnostic contrast agent and have great potential for therapeutic applications. Multiple emerging diagnostic and therapeutic applications and the numerous versatile parameters of the nanoparticle platform require a robust biological model for characterization and assessment. Here we investigate the use of iron oxide nanoparticles that target tumor vasculature, via the tumstatin peptide, in a novel three-dimensional tissue culture model. The developed tissue culture model more closely mimics the in vivo environment with a leaky endothelium coating around a glioma tumor mass. Tumstatin-iron oxide nanoparticles showed penetration and selective targeting to endothelial cell coating on the tumor in the three-dimensional model, and had approximately 2 times greater uptake in vitro and 2.7 times tumor neo-vascularization inhibition. Tumstatin provides targeting and therapeutic capabilities to the iron oxide nanoparticle diagnostic contrast agent platform. And the novel endothelial cell-coated tumor model provides an in vitro microtissue environment to evaluate nanoparticles without moving into costly and time-consuming animal models.
19
Inorganic Nanoparticles for MRI Contrast Agents
Hyon Bin Na, In Chan Song, Taeghwan Hyeon · Advanced Materials · 2009 · 1.8K citations
Spheroid-based drug screen: considerations and practical approach
Juergen Friedrich, Claudia Seidel, Reinhard Ebner et al. · Nature Protocols · 2009 · 1.7K citations